Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 50 min ago
Peer-reviewedCC BY-NC-NDOphthalmology science

Predictive Performance of Polygenic Risk Scores for Primary Open-Angle Glaucoma: A Systematic Review and Meta-Analysis.

  1. 1College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.
  2. 2Discipline of Ophthalmology & Visual Sciences, Adelaide University, Adelaide, South Australia, Australia.
  3. 3Department of Ophthalmology, University of Illinois Chicago, Chicago, Illinois.

Abstract

Purpose

To evaluate the predictive accuracy of polygenic risk scores (PRSs) for primary open-angle glaucoma (POAG) and quantify associations between polygenic burden and POAG risk, predictive performance, and glaucoma-related clinical features.Design

Systematic review and meta-analysis.Methods

The protocol was registered on the International Prospective Register of Systematic Review (CRD420251067047). A systematic search of PubMed identified 161 records; 41 articles underwent full-text review and 14 met inclusion criteria. Eligible studies included adult participants from population-based cohorts, case-control data sets, and randomized or observational designs assessing genetic susceptibility to POAG, with pooled analyses restricted to European-ancestry participants. The exposure was PRS derived from genome-wide association studies; primary outcomes were predictive performance (area under the curve [AUC]) and odds ratios for POAG. Heterogeneity was assessed using the I² statistic, and subgroup analyses examined PRS construction method and study design as potential sources. Secondary outcomes were associations between PRS and glaucoma-related structural or functional changes. Publication bias was assessed using funnel plots and Egger test, and random-effects models were applied given the substantial heterogeneity.Results

Across 14 studies (1 416 665 participants; nominal sum, reduced to approximately 692 000 after collapsing confirmed overlapping cohorts-UK Biobank and the Ocular Hypertension Treatment Study), PRS showed moderate predictive performance: individual study AUCs ranged from 0.65 to 0.82, with a pooled AUC of 0.75 (95% confidence interval [CI], 0.72-0.78; 10 of 14 studies with a usable AUC). Higher PRS was significantly associated with increased POAG risk on the harmonized per-standard deviation‑equivalent scale (pooled odds ratio, 1.70; 95% CI, 1.48-1.95; 9 of 14 studies). No conclusive evidence of publication bias was detected. Between-study heterogeneity was substantial, likely reflecting differences in genetic background, PRS construction, phenotype definitions, and study design; however, effect direction was consistent across studies, and influence diagnostics confirmed the robustness of the findings. Secondary outcomes, including higher intraocular pressure, faster visual field progression, and greater likelihood of glaucoma surgery, were also significantly associated with higher PRS.Conclusions

Polygenic risk score offers moderate but consistent risk stratification for POAG and demonstrates moderate predictive accuracy across diverse study designs. Although PRS shows promise for identifying genetically high-risk individuals earlier, substantial heterogeneity and limited ancestral diversity highlight the need for large-scale, multiethnic validation before PRS can enter routine clinical practice.Financial disclosures

Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Related

  1. Machine learning models for identifying prediabetes: a systematic review of performance, validation, and implications for primary care
    Liang Wang, Yan Zhang, Hao Yang +3
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Juvenile and adult open-angle glaucoma form a single polygenic continuum
    J. Schmidt, M. C. B. Guevarra, G. Ni +18
    medRxivPreprintCC BYFull textGeneral medicinemedRxiv
  3. Corneal higher-order aberration agreement among Pentacam HR, ACE, and iTrace in primary congenital glaucoma
    Zakieh Vahedian, Amin Ahmadi, Parisa Abdi +1
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textMedical imaging & radiologyCrossref
  4. Mitochondrial DNA Copy Number Is Associated With Visual Field Progression in Primary Open-Angle Glaucoma
    A. H. Pham, K. M. Kane, D. R. da Costa +1
    medRxivPreprintAll rights reservedFull textGeneral medicinemedRxiv
  5. Genetically Predicted Circulating Lipid Traits and Risk of Primary Open-Angle Glaucoma: A Mendelian Randomization Study
    Ahmed El Ashry, Mahmoud El Ashry, Hajirah N. Saeed +1
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{zidan2026predictive,
  title = {{Predictive Performance of Polygenic Risk Scores for Primary Open-Angle Glaucoma: A Systematic Review and Meta-Analysis.}},
  author = {Asmaa A Zidan and Abdullah Ahmed and Shahid Ullah and Robert Casson},
  journal = {Ophthalmology science},
  year = {2026},
  month = sep,
  doi = {10.1016/j.xops.2026.101405},
  url = {https://europepmc.org/article/MED/42926799},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Predictive Performance of Polygenic Risk Scores for Primary Open-Angle Glaucoma: A Systematic Review and Meta-Analysis.
AU  - Asmaa A Zidan
AU  - Abdullah Ahmed
AU  - Shahid Ullah
AU  - Robert Casson
PY  - 2026
DA  - 2026/09/10
JO  - Ophthalmology science
DO  - 10.1016/j.xops.2026.101405
UR  - https://europepmc.org/article/MED/42926799
AB  - Purpose  To evaluate the predictive accuracy of polygenic risk scores (PRSs) for primary open-angle glaucoma (POAG) and quantify associations between polygenic burden and POAG risk, predictive performance, and glaucoma-related clinical features.Design  Systematic review and meta-analysis.Methods  The protocol was registered on the International Prospective Register of Systematic Review (CRD420251067047). A systematic search of PubMed identified 161 records; 41 articles underwent full-text review and 14 met inclusion criteria. Eligible studies included adult participants from population-based cohorts, case-control data sets, and randomized or observational designs assessing genetic susceptibility to POAG, with pooled analyses restricted to European-ancestry participants. The exposure was PRS derived from genome-wide association studies; primary outcomes were predictive performance (area under the curve [AUC]) and odds ratios for POAG. Heterogeneity was assessed using the I² statistic, and subgroup analyses examined PRS construction method and study design as potential sources. Secondary outcomes were associations between PRS and glaucoma-related structural or functional changes. Publication bias was assessed using funnel plots and Egger test, and random-effects models were applied given the substantial heterogeneity.Results  Across 14 studies (1 416 665 participants; nominal sum, reduced to approximately 692 000 after collapsing confirmed overlapping cohorts-UK Biobank and the Ocular Hypertension Treatment Study), PRS showed moderate predictive performance: individual study AUCs ranged from 0.65 to 0.82, with a pooled AUC of 0.75 (95% confidence interval [CI], 0.72-0.78; 10 of 14 studies with a usable AUC). Higher PRS was significantly associated with increased POAG risk on the harmonized per-standard deviation‑equivalent scale (pooled odds ratio, 1.70; 95% CI, 1.48-1.95; 9 of 14 studies). No conclusive evidence of publication bias was detected. Between-study heterogeneity was substantial, likely reflecting differences in genetic background, PRS construction, phenotype definitions, and study design; however, effect direction was consistent across studies, and influence diagnostics confirmed the robustness of the findings. Secondary outcomes, including higher intraocular pressure, faster visual field progression, and greater likelihood of glaucoma surgery, were also significantly associated with higher PRS.Conclusions  Polygenic risk score offers moderate but consistent risk stratification for POAG and demonstrates moderate predictive accuracy across diverse study designs. Although PRS shows promise for identifying genetically high-risk individuals earlier, substantial heterogeneity and limited ancestral diversity highlight the need for large-scale, multiethnic validation before PRS can enter routine clinical practice.Financial disclosures  Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
SN  - 2666-9145
ER  -